Dopamine and noradrenaline releasing action of amantadine in the central and peripheral nervous system: a possible mode of action in Parkinson's disease.
D000547:Amantadine / Q000494:pharmacology*; D000818:Animals; D002395:Catecholamines / Q000096:biosynthesis; D002490:Central Nervous System / Q000187:drug effects*; D004298:Dopamine / Q000378:metabolism*; D004564:Electrocoagulation; D006614:Hindlimb; D006651:Histocytochemistry; D007700:Kinetics; D008297:Male; D009043:Motor Activity / Q000187:drug effects; D009526:Nialamide / Q000494:pharmacology; D009638:Norepinephrine / Q000378:metabolism*; D010300:Parkinson Disease / Q000188:drug therapy*; D010525:Peripheral Nerves / Q000187:drug effects*; D051381:Rats; D011919:Rats, Inbred Strains; D012018:Reflex / Q000187:drug effects; D012110:Reserpine / Q000494:pharmacology; D014316:Tritium
D002395:Catecholamines; D014316:Tritium; D012110:Reserpine; D000547:Amantadine; D009526:Nialamide; D004298:Dopamine; D009638:Norepinephrine